Melissa E Munroe
7PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 28, 2025
Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activity.Melissa E Munroe, Kendra Young, Rufei Lu
|Nov 21, 2023
Tracking of Systemic Lupus Erythematosus (SLE) Longitudinally Using Biosensor and Patient-Reported Data: A Report on the Fully Decentralized Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals-The OASIS Study.Eldon R Jupe, Gerald H Lushington, Mohan Purushothaman
|Oct 17, 2022
A Flare Risk Index Informed by Select Immune Mediators in Systemic Lupus Erythematosus.Melissa E Munroe, Derek Blankenship, Daniele DeFreese
|Nov 19, 2016
Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features.Melissa E Munroe, Kendra A Young, Diane L Kamen
|Jun 11, 2016
Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus.Kendra A Young, Melissa E Munroe, Joel M Guthridge
|Apr 19, 2016
Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.Melissa E Munroe, Rufei Lu, Yan D Zhao
Pageof 2
